Additionally, we identified a mutant form of Brd4 in Progressive supranuclear palsy patients, which attenuates the ability of Brd4 to promote cell competition by disrupting its interaction with the promoter of Spock2. The gene discussed is SPOCK2; the disease is Classical progressive supranuclear palsy.